An assessment of the annual and long-term direct costs of rheumatoid arthritis: The impact of poor function and functional decline

Arthritis and Rheumatism

Volumn 42, Issue 6, 1999, Pages 1209-1218

  Yelin, Edward ^a   Wanke, Lee A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ARTHRALGIA; ARTICLE; COST OF ILLNESS; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL FEE; MORNING STIFFNESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURGERY;

ARTHRITIS, RHEUMATOID; COHORT STUDIES; COSTS AND COST ANALYSIS; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; HEALTH CARE COSTS; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SAN FRANCISCO; SEVERITY OF ILLNESS INDEX;

EID: 0033001678     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199906)42:6<1209::AID-ANR18>3.0.CO;2-M     Document Type: Article

References (19)

1. Meenan RF, Yelin EH, Henke CJ, Curtis DL, Epstein WV. The costs of rheumatoid arthritis: a patient-oriented study of chronic disease costs. Arthritis Rheum 1978;21:827-33.
2. Liang MH, Larson M, Thompson M, Eaton H, McNamara E, Katz R, et al. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
3. Thompson M, Read J, Liang M. Feasibility of willingness to pay measurements in chronic arthritis. Med Decis Making 1984;4:195-212.
4. Lubeck D, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH. A multicenter study of annual health services utilization and costs in rheumatoid arthritis. Arthritis Rheum 1986;29:488-93.
5. Jacobs J, Keyserling J, Britton M, Morgan G, Wilkenfeld J, Hutchings C. The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the Medi-Cal program. J Clin Epidemiol 1988;41:215-33.
6. Allaire S, Prashker M, Meenan R. The cost of rheumatoid arthritis. Pharmacoeconomics 1994;6:513-22.
7. MacLean CH, Knight KK, Shekelle PG, Paulus HE, Brook RH. Costs attributable to arthritis implications of costs [abstract]. Arthritis Rheum 1996;39 Suppl 9:S317.
8. Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997;40:1475-81.
9. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997; 24:719-25.
10. Clarke A, Zowall H, Levinton C, Assimakopoulos H, Sibley J, Haga M, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a twelve year study. J Rheumatol 1997;24:1051-60.
11. Yelin E. The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates. J Rheumatol 1996;23 Suppl:47-51.
12. Yelin E, Henke C, Kramer J, Nevitt M, Shearn M, Epstein W. A comparison of the treatment of rheumatoid arthritis in HMOs and fee-for-service practices. N Engl J Med 1985;312:962-7.
13. Yelin E, Criswell L, Feigenbaum P. Health care utilization and outcomes over an eleven-year period among persons with rheumatoid arthritis in fee-for-service and HMO settings. JAMA 1996;276:1048-53.
14. Gabriel S, Tugwell P, O'Brien B, Yelin E, Drummond M, Ruff B, et al. Report of the OMERACT Task Force on Economic Evaluation. Rochester (MN): Mayo Clinic; 1998.
15. Drummond M. Economic analysis alongside clinical trials: problems and potential. J Rheumatol 1995;22:1403-7.
16. Health Care Consultants of America, Inc. 1996 physicians fee and coding guide. Atlanta: Health Care Consultants of America, Inc.; 1996.
17. Medical Economics, Inc. The 1996 red book. Montvale (NJ): Medical Economics, Inc.; 1996.
18. SAS Institute, Inc. SAS/STAT software: changes and enhancements through release 6.12. Cary (NC): SAS Institute, Inc.; 1997.
19. Singh G, Terry R, Ramey D, Wolfe F, Fries J. Long-term medical costs and outcomes are significantly associated with early changes in disability in rheumatoid arthritis [abstract]. Arthritis Rheum 1996;39 Suppl 9:S318.